Compounds > oxazoles
Page last updated: 2024-08-21

oxazoles and thromboxane b2

oxazoles has been researched along with thromboxane b2 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harris, DN; Misra, RN; Ogletree, ML; Schumacher, WA; Webb, ML1
Khwaja, S; Miao, L; Nanji, AA; Rahemtulla, A; Tahan, SR; Zhao, S1
Jakubowski, JA; Kohn, TJ; Mais, DE; Takeuchi, K; True, TA; Utterback, BG; Wikel, JH; Wyss, VL1
Iwamura, H; Matsushita, M; Tazaki, H; Wakitani, K1
Jungermann, K; Nath, A; Pestel, S; Schieferdecker, HL1

Other Studies

5 other study(ies) available for oxazoles and thromboxane b2

ArticleYear
Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 264, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Oral; Animals; Aorta; Bridged Bicyclo Compounds, Heterocyclic; Cattle; Coronary Vessels; Dinoprostone; Fatty Acids, Unsaturated; Guinea Pigs; Humans; Hydrazines; In Vitro Techniques; Male; Mice; Muscle Contraction; Oxazoles; Platelet Aggregation; Propionates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin; Receptors, Thromboxane; Swine; Thromboxane B2; Trachea

1993
Thromboxane inhibitors attenuate pathological changes in alcoholic liver disease in the rat.
    Gastroenterology, 1997, Volume: 112, Issue:1

    Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Fatty Liver, Alcoholic; Liver Diseases, Alcoholic; Male; Oxazoles; Rats; Rats, Wistar; Thromboxane A2; Thromboxane B2; Transforming Growth Factor alpha; Transforming Growth Factor beta

1997
Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 3. Synthesis and biological activities of oxazolecarboxamide-substituted omega-phenyl-omega-(3-pyridyl)alkenoic acid derivatives and related compoun
    Journal of medicinal chemistry, 1998, Dec-31, Volume: 41, Issue:27

    Topics: Animals; Blood Platelets; Drug Design; Enzyme Inhibitors; Epoprostenol; Heptanoic Acids; Humans; In Vitro Techniques; Oxazoles; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Structure-Activity Relationship; Thromboxane B2; Thromboxane-A Synthase

1998
JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2000, Volume: 49, Issue:3

    Topics: Animals; Benzenesulfonates; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Edema; Foot; Gastric Mucosa; Inflammation; Isoenzymes; Macrophages, Peritoneal; Male; Oxazoles; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Sprague-Dawley; Thromboxane B2

2000
Inhibition of prostaglandin D2 clearance in rat hepatocytes by the thromboxane receptor antagonists daltroban and ifetroban and the thromboxane synthase inhibitor furegrelate.
    Biochemical pharmacology, 2003, Aug-15, Volume: 66, Issue:4

    Topics: Animals; Benzofurans; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Complement C5a; Enzyme Inhibitors; Hepatocytes; Liver; Male; Metabolic Clearance Rate; Oxazoles; Perfusion; Phenylacetates; Prostaglandin D2; Rats; Rats, Wistar; Receptors, Thromboxane; Sulfonamides; Thromboxane B2; Thromboxane-A Synthase

2003